Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand

Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand

Upworthy

Published

Last week, Novavax Inc NVAX received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in individuals aged 12 and older. Wall Street analysts are optimistic about Novavax's prospects despite its vaccine's release delay compared to Pfizer Inc PFE and…

#novavaxincnvax #fda #novavax #pfizerincpfe #modernainc #jefferies #rogersong #nvax

Full Article